Novel AI Blood Test Detects Liver Cancer
A novel artificial intelligence blood testing technology has now detected more than 80% of liver cancers in a new study of 724 people. <br /><br />
Stay updated with breaking news from Epigenetics Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A novel artificial intelligence blood testing technology has now detected more than 80% of liver cancers in a new study of 724 people. <br /><br />
The test, developed by researchers at the Johns Hopkins Kimmel Cancer Center, aids in early detection of liver cancer—one of the leading causes of cancer deaths
A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.
A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA (mRNA) vaccines to deter cancer development in at-risk groups.
An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.